Creative Planning’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.73M Buy
38,899
+3,365
+9% +$839K 0.01% 788
2025
Q4
$8.56M Buy
35,534
+1,268
+4% +$324K 0.01% 684
2025
Q3
$9.38M Buy
34,266
+2,561
+8% +$700K 0.01% 595
2025
Q2
$8.18M Buy
31,705
+1,765
+6% +$421K 0.01% 577
2025
Q1
$6.7M Buy
29,940
+1,432
+5% +$334K 0.01% 614
2024
Q4
$6.52M Buy
28,508
+487
+2% +$117K 0.01% 579
2024
Q3
$6.84M Buy
28,021
+3,739
+15% +$835K 0.01% 547
2024
Q2
$4.65M Buy
24,282
+1,082
+5% +$220K 0.01% 645
2024
Q1
$4.59M Buy
23,200
+5,244
+29% +$961K 0.01% 631
2023
Q4
$3.09M Buy
17,956
+6,129
+52% +$942K 0.01% 733
2023
Q3
$1.75M Buy
11,827
+4,060
+52% +$734K ﹤0.01% 911
2023
Q2
$1.7M Buy
7,767
+901
+13% +$201K ﹤0.01% 894
2023
Q1
$1.5M Buy
6,866
+242
+4% +$52.5K ﹤0.01% 894
2022
Q4
$1.38M Buy
6,624
+102
+2% +$22.4K ﹤0.01% 886
2022
Q3
$1.42M Buy
6,522
+1,139
+21% +$259K ﹤0.01% 810
2022
Q2
$1.13M Buy
5,383
+1,120
+26% +$238K ﹤0.01% 923
2022
Q1
$1.03M Buy
4,263
+44
+1% +$10.6K ﹤0.01% 964
2021
Q4
$1.1M Buy
4,219
+63
+2% +$16.3K ﹤0.01% 913
2021
Q3
$1.09M Sell
4,156
-38
-0.9% -$10.4K ﹤0.01% 902
2021
Q2
$1.03M Sell
4,194
-2,678
-39% -$563K ﹤0.01% 925
2021
Q1
$1.33M Sell
6,872
-227
-3% -$45.5K ﹤0.01% 895
2020
Q4
$1.51M Sell
7,099
-247
-3% -$49.2K ﹤0.01% 776
2020
Q3
$1.26M Sell
7,346
-1,106
-13% -$204K ﹤0.01% 721
2020
Q2
$1.62M Sell
8,452
-1,702
-17% -$278K ﹤0.01% 569
2020
Q1
$1.5M Buy
10,154
+7,825
+336% +$1.25M 0.01% 514
2019
Q4
$361K Buy
2,329
+59
+3% +$8.5K ﹤0.01% 1294
2019
Q3
$307K Sell
2,270
-21
-0.9% -$2.75K ﹤0.01% 1352
2019
Q2
$280K Sell
2,291
-25
-1% -$2.77K ﹤0.01% 1416
2019
Q1
$241K Buy
2,316
+281
+14% +$29K ﹤0.01% 1469
2018
Q4
$232K Buy
2,035
+16
+0.8% +$1.71K ﹤0.01% 1386
2018
Q3
$233K Buy
2,019
+3
+0.1% +$329 ﹤0.01% 1574
2018
Q2
$209K Buy
+2,016
New +$204K ﹤0.01% 1622
2017
Q3
Sell
-1,671
Closed -$130K 3333
2017
Q2
$130K Buy
1,671
+823
+97% +$58.9K ﹤0.01% 1793
2017
Q1
$61K Sell
848
-560
-40% -$38.7K ﹤0.01% 2328
2016
Q4
$87K Buy
1,408
+204
+17% +$12.5K ﹤0.01% 1962
2016
Q3
$78K Buy
1,204
+404
+51% +$26.9K ﹤0.01% 2021
2016
Q2
$51K Sell
800
-409
-34% -$24.1K ﹤0.01% 2124
2016
Q1
$70K Hold
1,209
﹤0.01% 1865
2015
Q4
$65K Hold
1,209
﹤0.01% 1906
2015
Q3
$62K Buy
+1,209
New +$65.1K ﹤0.01% 1888
2015
Q2
Sell
-1,000
Closed -$72K 2601
2015
Q1
$72K Hold
1,000
﹤0.01% 1766
2014
Q4
$56K Sell
1,000
-475
-32% -$24.8K ﹤0.01% 1936
2014
Q3
$73K Buy
1,475
+615
+72% +$31.3K ﹤0.01% 1677
2014
Q2
$44K Hold
860
﹤0.01% 1950
2014
Q1
$38K Buy
860
+800
+1,333% +$35.9K ﹤0.01% 1978
2013
Q4
$3K Hold
60
﹤0.01% 3016
2013
Q3
$3K Hold
60
﹤0.01% 2904
2013
Q2
$3K Buy
+60
New +$2.85K ﹤0.01% 2728

Other funds holding RMD

Creative Planning's RMD Position: Q1 2026 in Review

Creative Planning increased its ResMed (RMD) stake by 9.5% in Q1 2026, buying an estimated $839K and bringing the position to 38,899 shares worth $8.73M. The position accounts for 0.01% of the portfolio, ranked #788.

Creative Planning first reported a position in RMD in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.38M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Creative Planning held 38,899 shares of ResMed worth $8.73M as of Q1 2026.
  • Creative Planning bought 3,365 ResMed shares in Q1 2026, an estimated $839K.
  • ResMed made up 0.01% of Creative Planning's portfolio in Q1 2026, its #788 holding.
  • Creative Planning first reported a position in ResMed in Q2 2013 and has held it in 48 quarters since.
  • Creative Planning's ResMed position peaked at $9.38M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.